Role of the extracellular domains of the cholecystokinin receptor in agonist binding

Molecular Pharmacology

Volumn 54, Issue 2, 1998, Pages 364-371

  Silvente Poirot, Sandrine ^a   Escrieut, Chantal ^a   Wank, Stephen A ^b,c  

^a CHU RANGUEIL   (France)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; GASTRIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; RADIOLIGAND; RECEPTOR SUBTYPE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; IMMUNOFLUORESCENCE; LIGAND BINDING; MONKEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0031818991     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.2.364     Document Type: Article

References (35)

1. Baldwin JM (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-1703.
2. Bone EA and Rosenzweig SA (1988) Characterization of cholecystokinin receptors in toad retina. Peptides 9:373-381.
3. Crawley JN and Corwin RL (1994) Biological actions of cholecystokinin. Peptides 15:731-755.
4. Dixon RA, Sigal IS, Candelore MR, Register RB, Rands E, and Strader CD (1987) Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J 6:3269-3275.
5. Field J, Nikawa J, Broek D, MacDonald B, Rodgers L, Wilson IA, Lerner RA, and Wigler M (1988) Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol 8:2159-2165.
6. Fong TM, Huang RR, and Strader CD (1992) Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J Biol Chem 267:25664-25667.
7. Gingrich JA and Caron MG (1993) Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16:299-321.
8. Gully D, Frehel D, Marcy C, Spinazze A, Lespy L, Neliat G, Maffrand JP, and Le Fur G (1993) Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. Ear J Pharmacol 232:13-19.
9. Hjorth SA, Schambye HT, Greenlee WJ, and Schwartz TW (1994) Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem 269:30953-30959.
10. Huang RC, Vicario PP, Strader CD, and Fong TM (1995) Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry 34:10048-10055.
11. Huang S, Fortune KP, Wank SA, Kopin AS, and Gardner JD (1994) Multiple affinity states of different cholecystokinin (CCK) receptors. J Biol Chem 269:26121-26126.
12. Hulme EC, Birdsall NJ, and Buckley JJ (1990) Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673.
13. Humphrey PP, Hartig P, and Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233-236.
14. Jagerschmidt A, Rousselet GN, Vikland ML, Goudreau N, Maigret B, and Roques BP (1996) His381 of the rat CCKB receptor is essential for CCKB versus CCKA, receptor antagonist selectivity. Eur J Pharmacol 296:97-106.
15. Karnik SS, Sakmar TP, Chen H, and Khorona HG (1988) Cysteine residues 180-187 are essential for the formation of the correct structure in bovine rhodopsin. Proc Natl Acad Sci USA 85:8459-8463.
16. Kennedy K, Escrieut C, Dufresne M, Clerc P, Vaysse N, and Fourmy D (1995) Identification of a region of the N-terminal of the human CCKA receptor essential for the high affinity interaction with agonist CCK. Biochem Biophys Res Commun 213:845-852.
17. Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Frehel D, Gully D, Vaysse N, and Fourmy D (1997) Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J Biol Chem 272:2920-2926.
18. Kim J, Wess J, van Rhee AM, Schoneberg T, and Jacobson KA (1995) Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor. J Biol Chem 270:13987-13997.
19. Kopin AS, McBride EW, Quinn SM, Kolakowski LF Jr, and Beinborn M (1995) The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands. J Biol Chem 270:5019-5023.
20. Leong SR, Kabakoff RC, and Hebert CA (1994) Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J Biol Chem 269:19343-19348.
21. Miyake A (1995) A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon. Biochem Biophys Res Commun 208:230-237.
22. Mouillac B, Chini B, Balestre M, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S, and Barberis C (1995) The binding site of neuropeptide vasopressin V1a receptor: evidence for a major localization within transmembrane regions. J Biol Chem 270:25771-25777.
23. Munson PJ and Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
24. Pirot SS, Dufresne M, Vaysse N, and Fourmy D (1993) The peripheral cholecystokinin receptors. Eur J Biochem 215:513-529.
25. Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, and Fourmy D (1994) Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Mol Pharmacol 45:599-607.
26. Poirot SS and Wank SA (1996) A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin. J Biol Chem 25:14698-14706.
27. Reisine T and Bell G (1993) Molecular biology of opioid receptors. Trends Neurosci 16:34-38.
28. Schertler GF, Villa C, and Henderson R (1993) Projection structure of rhodopsin. Nature (Lond) 362:770-772.
29. Schmitz F, Pratt DS, Wu MJ, Kolakowski LF Jr, Beinborn M, and Kopin AS (1996) Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor. Mol Pharmacol 50:436-441.
30. Schwartz TW and Rosenkilde MM (1996) Is there a 'lock' for all agonist 'keys' in 7TM receptors? Trends Pharmacol Sci 17:213-216.
31. Strader CD, Fong TM, Tota MR, Underwood D, and Dixon RA (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132.
32. Wank SA (1995) Cholecystokinin receptors. Am J Physiol 269:G628-G646.
33. Wank SA, Harkins RT, Jensen RT, Shapira H, de Weerth A, and Slattery T (1992) Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 89:3125-3129.
34. Wank SA, Pisegna JR, and de Weerth A (1992) Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 89:8691-8695.
35. Wu V, Yang M, McRoberts JA, Ren J, Seensalu R, Zeng N, Dagrag M, Birnbaumer M, and Walsh JH (1997) First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J Biol Chem 272:9037-9042.